Skip to search formSkip to main contentSkip to account menu

CVT 510

Known as: CVT-510 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

tecadenoson

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Electrophysiologic Disorders Termination of Paroxysmal Supraventricular Tachycardia by Tecadenoson ( CVT-510 ) , a Novel A 1-Adenosine Receptor Agonist
Termination of Paroxysmal Supraventricular Tachycardia by Tecadenoson (CVT-510), a Novel A1-Adenosine Receptor Agonist Eric N… 
2010
2010
INO-8875, a Highly-Selective A1 Adenosine Receptor Agonist: Evaluation of Chronotropic, Dromotropic and Hemodynamic Effects in Rats.
Publication of this article is suspended until the authors can provide full identification and verification of the chemical… 
Review
2002
Review
2002
CVT-510 (CV Therapeutics).
CVT-510, the lead compound from a series of selective adenosine A1 receptor agonists, is being developed by CV Therapeutics for… 
2000
2000
CVT-510 successfully terminates paroxysmal supraventricular tachycardia,
  • 2000
  • Corpus ID: 195139875
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)